Article
Is Obesity associated with poorer outcome in glioblastoma patients?
Search Medline for
Authors
Published: | May 13, 2014 |
---|
Outline
Text
Objective: Higher Body Mass Index (BMI) has been associated with higher risk of poor outcome in various cancers and is linked to a higher risk of cardiovascular complications. However, the influence of the initial bodyweight on patients with glioblastoma is unclear. Therefore we analyzed outcome, complications and overall survival in glioblatoma patients.
Method: We analyzed 471 consecutive patients (258 men / 213 women) in a single center institute. BMI was assesed at the time of the first surgery and was classified according to the WHO grading (normal weight <25, overweight 25-30, obese >30). The data was collected from January 2006 to December 2011. We included the following parameters: progressionfree survival, overall survival, postoperative complications (symptomatic bleeding, new neurological deficits, ischemia, infeciton, TVT/LE), hospital stay/ICUstay, extent of resection according to 72h postoperative MRI and pre/post operative KPS.
Results: The BMI did not influence the overall survival of all glioblastoma patients. None of the other parameters assessed were influenced by the BMI. Focusing on different complications, the infection rate was significantly (12/471) lower in the overweight patient group, compared to the normal weight and obese glioblastoma patients. The extent of the resection was distributed equally among the three BMI groups. The length of the hospital stay was related to complications, but not to the BMI.
Conclusions: Obese Glioblastoma patients per se do not have a poorer outcome or higher complication rates according to this single center study. Interestingly, overweight patients had significantly lower postoperative infection rates compared to normal weight and obese patients.